Hangzhou Longda New-Tech Bio-pharmaceutical

Hangzhou Longda New-Tech Bio-pharmaceutical is a specialized biotechnology company based in China that focuses on the extraction, purification, and manufacturing of biological medicines. The company is a prominent producer of therapeutic enzymes and hormones derived from natural biological sources, most notably Urokinase, Human Chorionic Gonadotropin (HCG), and Human Menopausal Gonadotropin (HMG). Established in the mid-1990s, the firm operates advanced manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to serve both domestic and international markets. Their product portfolio primarily addresses critical needs in cardiovascular health and reproductive medicine. By maintaining a focus on high-purity biological extracts, the company has positioned itself as a key supplier of active pharmaceutical ingredients (APIs) and finished dosage forms in the global biopharmaceutical supply chain.